Terbutaline Sulfate (Athenex Pharmaceutical Division, LLC.)
Welcome to the PulseAid listing for the Terbutaline Sulfate drug offered from Athenex Pharmaceutical Division, LLC.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Athenex Pharmaceutical Division, LLC. |
NON-PROPRIETARY NAME: | terbutaline sulfate |
SUBSTANCE NAME: | TERBUTALINE SULFATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | |
ROUTE: | SUBCUTANEOUS |
DOSAGE FORM: | INJECTION, SOLUTION |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2017-02-22 |
END MARKETING DATE: | 0000-00-00 |
Terbutaline Sulfate HUMAN PRESCRIPTION DRUG Details:
Item Description | Terbutaline Sulfate from Athenex Pharmaceutical Division, LLC. |
LABELER NAME: | Athenex Pharmaceutical Division, LLC. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 1(mg/mL) |
START MARKETING DATE: | 2017-02-22 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 70860-801_e7b13fa5-b6a9-4ae3-b14b-991ae431e117 |
PRODUCT NDC: | 70860-801 |
APPLICATION NUMBER: | ANDA200122 |
Other TERBUTALINE SULFATE Pharmaceutical Manufacturers / Labelers: